FDA Inspection
Charles River Laboratories, Inc.Charles River Laboratories, Inc. – FDA Inspection, Jan 4, 2024
Record Details
This FDA Inspection record concerns Charles River Laboratories, Inc., with an inspection on January 4, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · dc122024-4adc-46f4-995c-7a0e3a1f4d6c
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1226433
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.100(a)Absence of Written Procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Charles River Laboratories, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| January 20, 2026 | NAI | Drug Quality Assurance | |
| January 17, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 20, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 15, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 8, 2010 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Charles River Laboratories, Inc.
- FDA Inspection 1303694 - 2026-01-20
- FDA Inspection 1077885 - 2019-01-17
- FDA Inspection 923832 - 2015-04-20
- FDA Inspection 772763 - 2012-03-15
- FDA Inspection 638033 - 2010-01-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.